ARTICLE | Clinical News
Narurapid regulatory update
April 4, 2017 9:49 PM UTC
Japan approved Narurapid hydromorphone tablets from Daiichi to treat cancer pain. The product is an immediate-release formulation of hydromorphone. Daiichi also said Japan approved Narusus hydromorpho...
BCIQ Company Profiles
BCIQ Target Profiles